Grimaldi, Gabriela http://orcid.org/0000-0003-2435-7867
Cancian, Giuseppe
Rizzato, Angelica
Casanova, Alex
Perruchoud-Ader, Kathrin
Clerici, Michele
Consigli, Andrea
Menghini, Moreno
Funding for this research was provided by:
Bayer Switzerland AG (50000 CHF)
Article History
Received: 25 August 2023
Revised: 16 October 2023
Accepted: 15 November 2023
First Online: 4 December 2023
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the local ethics committee of Canton Ticino (2023–00653 CE 4340) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.
: G. Grimaldi provided consulting and/or speaker services for Apellis, Bayer and Roche. M. Menghini provided consulting and/or speaker services for Bayer, Roche, Novartis, Apellis and AbbVie, and is CMO and holds equity of Endogena Inc. All authors received an unrestricted research grant from Bayer AG Switzerland.